Scilex Holding Company (SCLX)
$2.92-1.35%Close
SELLCRISIS · day 12
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $25M
- Beta
- 1.72
- P/E (TTM)
- -0.06
- Short % float
- 2.28%
- Days to cover
- 5.8
- SI change
- -3.1%
- 1W
- -28.08%
- 1M
- -42.18%
- vs SPY 1W
- -29.24%
- vs SPY 1M
- -45.17%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on SCLX?
- LOPJLB’s latest quantitative signal on Scilex Holding Company (SCLX) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is SCLX in?
- Scilex Holding Company (SCLX) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Scilex Holding Company (SCLX) do?
- Scilex Holding Company is a biopharmaceutical enterprise that specializes in the development and market introduction of non-opioid therapies designed to alleviate both acute and chronic pain. Its primary marketed offering is ZTlido 1.8%, a topical prescription formulation of lidocaine specifically engineered to mitigate neuropathic discomfort associated with post-herpetic neuralgia, a condition…